Company profile

Microbot Medical

Surgical AI & Robotics

Company profile

About Microbot Medical

Microbot Medical is a medical device company pioneering a new category of single-use robotic systems for interventional procedures. The company's flagship product, LIBERTY® Endovascular Robotic System, is the first disposable, remotely operated robotic platform designed for peripheral vascular navigation. The system enables interventional physicians to perform endovascular procedures from a seated position with remote control guidance, delivering precise catheter and guidewire manipulation while significantly reducing radiation exposure. LIBERTY® was designed to lower traditional barriers to robotic adoption by eliminating the need for large capital equipment, extensive infrastructure changes, or additional staffing resources. The compact, single-use design integrates seamlessly into existing workflows while maintaining the precision and responsiveness physicians require. Clinical evidence from the ACCESS-PVI trial demonstrated 100% successful robotic navigation across all cases with zero adverse device effects and a 92% relative reduction in operator radiation exposure. The company serves interventional radiologists, vascular surgeons, and interventional cardiologists performing peripheral vascular procedures. Microbot Medical's mission is to deliver transformative interventional robotic solutions that prioritize patient care, empower providers, and enable access to advanced care anytime, anywhere. Led by co-founder and CEO Harel Gadot, the company is transitioning from clinical studies to commercialization, positioning itself to redefine the future of minimally invasive interventional procedures through accessible robotic technology.

Company description Microbot Medical official website

Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Microbot Medical?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Endovascular interventions
  • Interventional oncology procedures
  • Peripheral vascular disease

Who it serves

  • Health systems
  • Hospitals with catheterization labs
  • Interventional cardiologists
  • Interventional radiologists
  • Vascular surgeons

Deployment & integration

On Premise deployment with recorded integration context.

Geographic context

MarketsAfrica · Europe · Middle East · United States
Company sourceOfficial website

Company milestones

Platform expansion

Completed ACCESS-PVI clinical trial with successful outcomes, transitioning from clinical studies to commercialization phase, building commercial sales team

Partnerships

Recorded partners

  • Boston Scientific Corporation (via MEDX Xelerator connection)
  • Intellectual Ventures (via MEDX Xelerator connection)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Vascular Solutions

First single-use, remotely operated endovascular robotic system for peripheral navigation

Device · On PremiseCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

In Vivo Evaluation of a Disposable Endovascular Robotic System for Arterial Peripheral Vascular Interventions: A Multicenter Feasibility Study.

Journal of vascular and interventional radiology : JVIR · May 1, 2026

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

100% successful robotic navigation

All cases in ACCESS-PVI trial

0 adverse device effects

ACCESS-PVI trial safety profile

92% relative reduction in radiation exposure

Operator radiation exposure during procedures

ACCESS-PVI Clinical Trial

Remote-controlled endovascular navigation with miniature robotic system

100% successful robotic navigation, 0 adverse device effects, 92% relative reduction in radiation exposure

Institut Gustave Roussy Cancer Center

Interventional oncology procedures using LIBERTY system

Easy setup and effortless target navigation for interventional oncology

Miami Cardiac & Vascular Institute

Robotic interventional procedures replacing bulky capital equipment

Completed over 100 robotic cases; LIBERTY breaks down barriers compared to larger equipment

Timone Hospital

Clinical adoption of LIBERTY Robotic System for interventional radiology

Physician endorsement addressing clinical and financial needs

Yale Medical Center

Adoption of robotic endovascular system for interventional procedures

Physician endorsement for future of robotics in interventional field

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Harel Gadot

Harel Gadot

CEO, President and Chairman

LinkedIn

Simon Sharon

GM, Chief Technology Officer

Rachel Vaknin

Chief Financial Officer

Juan Diaz-Cartelle

Chief Medical Officer

Earl Adamy

VP, Strategic Marketing & Business Development

LinkedIn

Christina Bailey

VP, Sales

Eran Cohen

VP, Global Integration

Naama Moav

VP, Human Resources

06 · Company updates

Updates from Microbot Medical

Recent articles published on Microbot Medical's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Surgical AI & Robotics

Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon